These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4208311

  • 1. [Changes induced by poly-2-vinylpyridine-N-oxide in susceptibility of macrophages to tubercular infection].
    Briatico-Vangosa G, Chiappino G.
    Med Lav; 1973; 64(7):283-7. PubMed ID: 4208311
    [No Abstract] [Full Text] [Related]

  • 2. [Detoxicating effects of poly-2-vinylpyridine-N-oxide].
    Antweiler H.
    Beitr Silikoseforsch Pneumokoniose; 1970; 22(3):93-172. PubMed ID: 4325737
    [No Abstract] [Full Text] [Related]

  • 3. Abrogation of resistance to bone marrow grafts by silica particles. Prevention of the silica effect by the macrophage stabilizer poly-2-vinylpyridine N-oxide.
    Lotzová E, Cudkowicz G.
    J Immunol; 1974 Sep; 113(3):798-803. PubMed ID: 4369740
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of polyvinylpyridine-N-oxide on phagocytic activity of the reticuloendothelial system].
    Nothdurft W, Flemming K.
    Naunyn Schmiedebergs Arch Pharmakol; 1970 Sep; 267(4):341-52. PubMed ID: 4249229
    [No Abstract] [Full Text] [Related]

  • 5. Reactions of alveolar macrophages during short-term dust exposure with and without various pharmacological substances (glucocorticoids and PVN-oxide).
    Rasche B.
    Inhaled Part; 1970 Sep; 1():391-401. PubMed ID: 5527718
    [No Abstract] [Full Text] [Related]

  • 6. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN, Ozerova LV, Mordovskoĭ GG.
    Probl Tuberk; 1975 Sep; (3):67-9. PubMed ID: 1135207
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of aerosol administered poly-2-vinylpyridin-N-oxid(PVPNO) on the cellular pulmonary clearance].
    Rasche B, Würfel P, Ulmer WT.
    Beitr Silikoseforsch Pneumokoniose; 1970 Sep; 22(4):175-89. PubMed ID: 5537945
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Mechanism of protective action of polyvinylpyridine-N-oxide].
    Shnaĭdman IM.
    Gig Tr Prof Zabol; 1974 Jan; 18(1):19-23. PubMed ID: 4839818
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Increased phagocytosis in the reticuloendothelial system due to polyvinylpyridine-N-oxide].
    Flemming K, Nothdurft W.
    Klin Wochenschr; 1968 Aug 15; 46(16):904-5. PubMed ID: 5727479
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Secondary effects of parenterally administered polymeric compounds (polyvinylpyridine-N-oxide)].
    Lushnikova GA, Dubovik BV, Shadurskii KS, Lushnikov EF.
    Farmakol Toksikol; 1972 Aug 15; 35(3):363-6. PubMed ID: 5047309
    [No Abstract] [Full Text] [Related]

  • 17. Phagocytosis and intracellular fate of Mycobacterium tuberculosis: in vitro studies with guinea pig peritoneal and alveolar mononuclear phagocytes.
    Maxwell KW, Marcus S.
    J Immunol; 1968 Jul 15; 101(1):176-82. PubMed ID: 4969528
    [No Abstract] [Full Text] [Related]

  • 18. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S, Maneekarn N, Makonkawkeyoon L, Makonkawkeyoon S.
    Tuberculosis (Edinb); 2007 Mar 15; 87(2):130-3. PubMed ID: 16860611
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.